{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:25:50Z","timestamp":1753892750853,"version":"3.41.2"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD36071"],"award-info":[{"award-number":["HD36071"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["CF06\/0269"],"award-info":[{"award-number":["CF06\/0269"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Fragile X Associated Tremor\/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder affecting carriers of premutation alleles (PM) of the X-linked FMR1 gene, which contain CGG repeat expansions of 55\u2013200 range in a non-coding region. This late-onset disorder is characterised by the presence of tremor\/ataxia and cognitive decline, associated with the white matter lesions throughout the brain, especially involving the middle cerebellar peduncles. Nearly half of older male and ~ 20% of female PM carriers develop FXTAS. While there is evidence for mitochondrial dysfunction in neural and some peripheral tissues from FXTAS patients (though less obvious in the non-FXTAS PM carriers), the results from peripheral blood mononuclear cells (PBMC) are still controversial. Motor, cognitive, and neuropsychiatric impairments were correlated with measures of mitochondrial and non-mitochondrial respiratory activity, AMPK, and TORC1 cellular stress-sensing protein kinases, and CGG repeat size, in a sample of adult FXTAS male and female carriers. Moreover, the levels of these cellular measures, all derived from Epstein- Barr virus (EBV)- transformed and easily accessible blood lymphoblasts, were compared between the FXTAS (<jats:italic>N<\/jats:italic>= 23) and non-FXTAS (<jats:italic>n<\/jats:italic>= 30) subgroups, and with baseline data from 33 healthy non-carriers. A significant hyperactivity of cellular bioenergetics components as compared with the baseline data, more marked in the non-FXTAS PMs, was negatively correlated with repeat numbers at the lower end of the CGG-PM distribution. Significant associations of these components with motor impairment measures, including tremor-ataxia and parkinsonism, and neuropsychiatric changes, were prevalent in the FXTAS subgroup. Moreover, a striking elevation of AMPK activity, and a decrease in TORC1 levels, especially in the non-FXTAS carriers, were related to the size of CGG expansion. The bioenergetics changes in blood lymphoblasts are biomarkers of the clinical status of FMR1 carriers. The relationship between these changes and neurological involvement in the affected carriers suggests that brain bioenergetic alterations are reflected in this peripheral tissue. A possible neuroprotective role of stress sensing kinase, AMPK, in PM carriers, should be addressed in future longitudinal studies. A decreased level of TORC1\u2014the mechanistic target of the rapamycin complex, suggests a possible future approach to therapy in FXTAS.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.747268","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T04:52:11Z","timestamp":1637556731000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Cellular Bioenergetics and AMPK and TORC1 Signalling in Blood Lymphoblasts Are Biomarkers of Clinical Status in FMR1 Premutation Carriers"],"prefix":"10.3389","volume":"12","author":[{"given":"Danuta Z.","family":"Loesch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Q.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire Y.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Sanislav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R. W.","family":"Ngoei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Annesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsdon","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/386296","article-title":"The fragile-X premutation: a maturing perspective","volume":"74","author":"Hagerman","year":"2004","journal-title":"Am J Hum Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/978-1-4614-5434-2_6","article-title":"Unstable mutations in the FMR1 gene and the phenotypes","volume":"769","author":"Loesch","year":"2012","journal-title":"Adv Exp Med Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"Rodriguez-Revenga","year":"2009","journal-title":"Eur J Hum Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1474-4422(13)70125-X","article-title":"Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor\/ataxia syndrome","volume":"12","author":"Hagerman","year":"2013","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fmolb.2020.577246","article-title":"Differential progression of motor dysfunction between male and female fragile x premutation carriers reveals novel aspects of sex-specific neural involvement","volume":"7","author":"Loesch","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome-features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B8","first-page":"1757","article-title":"Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction","volume":"23","author":"Brunberg","year":"2002","journal-title":"AJNR Am J Neuroradiol."},{"key":"B9","doi-asserted-by":"crossref","first-page":"P2.125","DOI":"10.1212\/WNL.84.14_supplement.P2.125","article-title":"The splenium of the corpus callosum sign in fragile x associated tremor ataxia syndrome (FXTAS) (P2.125)","volume":"84","author":"Hermanson","year":"2015","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archneur.65.4.495","article-title":"Abnormal nerve conduction features in fragile X premutation carriers","volume":"65","author":"Soontarapornchai","year":"2008","journal-title":"Arch Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1866-1955-6-30","article-title":"Associated features in females with an FMR1 premutation","volume":"6","author":"Wheeler","year":"2014","journal-title":"J Neurodev Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","article-title":"Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"69","author":"Adams","year":"2007","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajmg.b.31189","article-title":"White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism","volume":"156","author":"Loesch","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/brain\/awf184","article-title":"Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers","volume":"125","author":"Greco","year":"2002","journal-title":"Brain."},{"key":"B16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mds.20753","article-title":"Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical\u2013pathological study","volume":"21","author":"Louis","year":"2006","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.juro.2006.11.097","article-title":"Testicular and pituitary inclusion formation in fragile X associated tremor\/ataxia syndrome","volume":"177","author":"Greco","year":"2007","journal-title":"J Urol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00401-011-0860-9","article-title":"Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor\/ataxia syndrome and CGG knock-in mice","volume":"122","author":"Hunsaker","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1136\/jmg.2003.012518","article-title":"Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor\/ataxia syndrome","volume":"41","author":"Tassone","year":"2004","journal-title":"J Med Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0896-6273(03)00533-6","article-title":"RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila","volume":"39","author":"Jin","year":"2003","journal-title":"Neuron."},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4172\/2168-975X.1000119","article-title":"Molecular advances leading to treatment implications for fragile x premutation carriers","volume":"3","author":"Polussa","year":"2014","journal-title":"Brain Disord Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron."},{"key":"B24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ejmg.2017.11.001","article-title":"Potential pathogenic mechanisms underlying Fragile X Tremor ataxia syndrome: RAN translation and\/or RNA gain-of-function?","volume":"61","author":"Boivin","year":"2018","journal-title":"Eur J Med Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s40478-019-0796-1","article-title":"Composition of the intranuclear inclusions of Fragile X-associated Tremor\/Ataxia syndrome","volume":"7","author":"Ma","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/nyas.12693","article-title":"Fragile X-associated tremor\/ataxia syndrome","volume":"1338","author":"Hagerman","year":"2015","journal-title":"Ann N Y Acad Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.nbd.2020.104740","article-title":"Fragile X syndrome and associated disorders: clinical aspects and pathology","volume":"136","author":"Salcedo-Arellano","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41436-019-0733-5","article-title":"Clustering of comorbid conditions among women who carry an FMR1 premutation","volume":"22","author":"Allen","year":"2020","journal-title":"Genet Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fpsyt.2018.00564","article-title":"Fragile X-associated neuropsychiatric disorders (FXAND)","volume":"9","author":"Hagerman","year":"2018","journal-title":"Front Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/BJ20091960","article-title":"Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome","volume":"429","author":"Ross-Inta","year":"2010","journal-title":"Biochem J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1007\/s12035-016-0194-7","article-title":"Impaired mitochondrial function and dynamics in the pathogenesis of FXTAS","volume":"54","author":"Alvarez-Mora","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s12311-016-0779-8","article-title":"Altered ze FMR1 premutation before the onset of the neurodegenerative disease fragile X-associated tremor\/ataxia syndrome","volume":"15","author":"Napoli","year":"2016","journal-title":"Cerebellum."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e12565","DOI":"10.1111\/gbb.12565","article-title":"Fragile X-associated tremor\/ataxia syndrome: regional decrease of mitochondrial DNA copy number relates to clinical manifestations","volume":"18","author":"Alvarez-Mora","year":"2019","journal-title":"Genes Brain Behav."},{"key":"B34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2014.11.058","article-title":"Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor\/ataxia syndrome","volume":"1598","author":"Ariza","year":"2015","journal-title":"Brain Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fgene.2018.00338","article-title":"Impact of FMR1 premutation on neurobehavior and bioenergetics in young monozygotic twins","volume":"9","author":"Napoli","year":"2018","journal-title":"Front Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fmolb.2020.578640","article-title":"Characterization of the metabolic, clinical and neuropsychological phenotype of female carriers of the premutation in the X-Linked FMR1 gene","volume":"7","author":"Napoli","year":"2020","journal-title":"Front Mol Biosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1471-4159.2012.07936.x","article-title":"Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model","volume":"123","author":"Kaplan","year":"2012","journal-title":"J Neurochem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnins.2016.00159","article-title":"Premutation in the Fragile X Mental Retardation 1 (FMR1) gene affects maternal zn-milk and perinatal brain bioenergetics and scaffolding","volume":"10","author":"Napoli","year":"2016","journal-title":"Front Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000446803","article-title":"Novel blood biomarkers are associated with white matter lesions in Fragile X- associated tremor\/ataxia syndrome","volume":"17","author":"Loesch","year":"2017","journal-title":"Neurodegener Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fgene.2018.00531","article-title":"The spectrum of neurological and white matter changes and premutation status categories of older male carriers of the FMR1 Alleles are linked to genetic (CGG and FMR1 mRNA) and cellular stress (AMPK) markers","volume":"9","author":"Loesch","year":"2018","journal-title":"Front Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"a019141","DOI":"10.1101\/cshperspect.a019141","article-title":"The opposing actions of target of rapamycin and AMP-activated protein kinase in cell growth control","volume":"7","author":"Hindupur","year":"2015","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s42255-019-0157-1","article-title":"mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress","volume":"2","author":"Ling","year":"2020","journal-title":"Nat Metab."},{"key":"B44","first-page":"293","article-title":"UPDRS Development Committee. \u201cThe Unified Parkinson's disease rating scale,\u201d","volume-title":"Recent Developments in Parkinson's Disease","author":"Fahn","year":"1987"},{"key":"B45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. the ataxia neuropharmacology committee of the world federation of neurology","volume":"145","author":"Trouillas","year":"1997","journal-title":"J Neurol Sci."},{"key":"B46","first-page":"271","article-title":"Clinical rating scale for tremor","volume-title":"Parkinson's Disease and Movement Disorders","author":"Fahn","year":"1993"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/gps.1610","article-title":"The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int J Geriatr Psychiatry."},{"volume-title":"The Wechsler Adult Intelligence Scale","year":"1997","author":"Wechsler","key":"B48"},{"volume-title":"Symbol Digit Modalities Test","year":"1982","author":"Smith","key":"B49"},{"key":"B50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/13854049108403297","article-title":"The hopkins verbal learning test: development of a new memory test with six equivalent forms","volume":"5","author":"Brandt","year":"1991","journal-title":"Clin Neuropsychol."},{"volume-title":"SCL-90-R: Symptom checklist-90-R. Administration, scoring and procedures manual 3 edn.","year":"1994","author":"Derogatis","key":"B51"},{"key":"B52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","article-title":"A. rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations","volume":"10","author":"Tassone","year":"2008","journal-title":"J Mol Diagn."},{"key":"B53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","article-title":"A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome","volume":"56","author":"Filipovic-Sadic","year":"2010","journal-title":"Clin Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1242\/dmm.025684","article-title":"Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity","volume":"9","author":"Annesley","year":"2016","journal-title":"Dis Model Mech."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/ijms21031074","article-title":"An isolated complex v inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME\/CFS Patients","volume":"21","author":"Missailidis","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1074\/jbc.271.2.611","article-title":"Mammalian AMP-activated protein kinase subfamily","volume":"271","author":"Stapleton","year":"1996","journal-title":"J Biol Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1866-1955-6-31","article-title":"Emerging topics in FXTAS","volume":"6","author":"Hall","year":"2014","journal-title":"J Neurodev Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2013.03.070","article-title":"Effects of nitric oxide on cell proliferation: novel insights","volume":"62","author":"Napoli","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2119\/molmed.2016.00122","article-title":"Altered redox mitochondrial biology in the neurodegenerative disorder fragile x-tremor\/ataxia syndrome: use of antioxidants in precision medicine","volume":"22","author":"Song","year":"2016","journal-title":"Mol Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1096\/fj.201600315R","article-title":"Warburg effect linked to cognitive-executive deficits in FMR1 premutation","volume":"30","author":"Napoli","year":"2016","journal-title":"FASEB J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.3390\/ijms22094536","article-title":"Lymphoblastoid cell lines as models to study mitochondrial function in neurological disorders","volume":"22","author":"Annesley","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fneur.2019.00832","article-title":"Total and regional white matter lesions are correlated with motor and cognitive impairments in carriers of the FMR1 premutation","volume":"10","author":"Hocking","year":"2019","journal-title":"Front Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/mds.27553","article-title":"Microglial cell activation and senescence are characteristic of the pathology FXTAS","volume":"33","author":"Mart\u00ednez","year":"2018","journal-title":"Mov Disord."},{"key":"B64","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fncel.2015.00440","article-title":"Are microglial cells the regulators of lymphocyte responses in the CNS?","volume":"9","author":"Almolda","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1098\/rsif.2017.0774","article-title":"Keeping the home fires burning: AMP-activated protein kinase","volume":"15","author":"Hardie","year":"2018","journal-title":"J R Soc Interface."},{"key":"B66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/hmg\/ddp497","article-title":"Fibroblast phenotype in male carriers of FMR1 premutation alleles","volume":"19","author":"Garcia-Arocena","year":"2010","journal-title":"Hum Mol Genet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1093\/hmg\/ddi394","article-title":"Induction of inclusion formation and disruption of lamin A\/C structure by premutation CGG-repeat RNA in human cultured neural cells","volume":"14","author":"Arocena","year":"2005","journal-title":"Hum Mol Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.3390\/ijms19113314","article-title":"Reciprocal regulation of AMPK\/SNF1 and protein acetylation","volume":"19","author":"Vancura","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1001240","DOI":"10.1371\/journal.pgen.1001240","article-title":"histone deacetylases suppress CGG repeat\u2013induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome","volume":"6","author":"Todd","year":"2010","journal-title":"PLoS Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1091\/mbc.e06-09-0881","article-title":"Diverse cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase signaling","volume":"18","author":"Bokko","year":"2007","journal-title":"Mol Biol Cell."},{"key":"B71","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12272-015-0549-z","article-title":"The double-edged sword of AMPK signaling in cancer and its therapeutic implications","volume":"38","author":"Jeon","year":"2015","journal-title":"Arch Pharm Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat Rev Drug Discov."},{"key":"B73","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/EBC20170027","article-title":"mTORC1 as the main gateway to autophagy","volume":"61","author":"Rabanal-Ruiz","year":"2017","journal-title":"Essays Biochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2020.08.034","article-title":"A cellular mechanism to detect and alleviate reductive stress","volume":"183","author":"Manford","year":"2020","journal-title":"Cell."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1089\/ars.2019.7803","article-title":"Metabolic responses to reductive stress","volume":"32","author":"Xiao","year":"2020","journal-title":"Antioxid Redox Signal."},{"key":"B76","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.3390\/ijms221910393","article-title":"Relationships between mitochondrial function, AMPK, and TORC1 signaling in lymphoblasts with premutation alleles of the FMR1 gene","volume":"22","author":"Fisher","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1093\/hmg\/dds348","article-title":"Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice","volume":"21","author":"Lu","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fneur.2018.00208","article-title":"Inhibition of mTORC1 signaling reverts cognitive and affective deficits in a mouse model of Parkinson's Disease","volume":"9","author":"Masini","year":"2018","journal-title":"Front Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1017\/thg.2021.10","article-title":"'Essential tremor' phenotype in FMR1 premutation\/gray zone sibling series: exploring possible genetic modifiers","volume":"24","author":"Loesch","year":"2021","journal-title":"Twin Res Hum Genet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajmg.b.30786","article-title":"Mood and anxiety disorders in females with the FMR1 premutation","author":"Roberts","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4088\/JCP.09m05407blu","article-title":"Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers","volume":"72","author":"Bourgeois","year":"2011","journal-title":"J Clin Psychiatry."},{"key":"B82","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4088\/JCP.08r04476","article-title":"A review of fragile X premutation disorders: expanding the psychiatric perspective","volume":"70","author":"Bourgeois","year":"2009","journal-title":"J Clin Psychiatry."},{"key":"B83","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cge.12347","article-title":"Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion","volume":"87","author":"Loesch","year":"2015","journal-title":"Clin Genet."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.747268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:52:03Z","timestamp":1726170723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.747268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":83,"alternative-id":["10.3389\/fpsyt.2021.747268"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.747268","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"article-number":"747268"}}